| Comunicación Nº: 078 | English version  |
| Comunicación Nº: 078 | English version |
Ramon Bosch-Príncep, Salomé Martínez-González, Tomás Álvaro-Naranjo, Mª Teresa Salvadó-Usach, Edelmira Barberá-Montesinos, Francisco Javier Ferrando-Roqueta, Miquel Crespi-Arimón, Manuel Estévez-Fernandez, Montserrat Llobera-Serentill
[Título] [Introducción] [Material y Métodos] [Resultados] [Iconografía] [Discusión] [Comentarios]
|
|
1.-Santa Cruz DJ. Malignant Melanoma Microstaging. A Call for Standardization. En: 5º Curso de Patología. Gutiérrez-Hoyos A. San Sebastián: Gutierrez-Hoyos, 1995.
2. Leslie KO, Rosai J. Standarization of the surgical pathology report: formats, templates, and synoptic reports. Sem Diagn Pathol 1994;1L(4):253-7.
3. Rosai J, Erlandson RA, Filippa DA, Gerald WL, Huvos AG, Klimistra DS et al. Standardized Reporting of Surgical Pathology Diagnoses for Mayor Tumor Types. Am J Clin Pathol 1993; 100:240-255.
4. Heenan P, Sobin L.H. Histological Typig of Skin tumours. World Health Organization. International Histological Classification of Tumors. Sobin LH. Berlin: Springer-Verlag, 1996.
5. Clark WH Jr. A classification of malignant melanoma in man correlated with histogenesis and biologic behavior. In: Advances in the biology of the skin; vol VIII. New york: Pergamon Press, 1967:621-647.
6. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970;172:902-908.
7. Cochran AJ. Method of assessing prognosis in patients with malignant melanoma. Lancet 1968;2:1062-1064.
8. Kopf AW, Gross DF, Rogers GS, Rigel DS, Hellman LJ, Levenstein M et al. Pronostic Index for Malignant Melanoma. Cancer 1987; 59:1236-1241.
9. Schmoeckel C, Braun-Falco O. Pronostic index in malignant melanoma. Arch Dermatol 1978:114:871-873.
10. Elder DE, Murphy GF. Atlas of tumor pathology. Melanocytic tumors of the skin. Whashington: AFIP, 1991:103-212.
11. Day CL Jr, Harrist TJ, Gorstein F et al. Malignant melanoma. Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat. Ann Surg 1981;194:108-112.
12. Hemanek P, Sobin LH. TNM Classification of Malignant Tumors. International Union Against Cancer. Berlin: Springer-Verlag, 1987.
13. Thorn M, Ponten F, Berstrome R, et al. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Swede. J Natl Cancer Inst 1994;86:761-769.
14. Balch CM, Soong SJ, Shaw HM. An analysis of prognaostic factors in 8500 patients with cutaneous melanoma. In: Balch CM, Houghton AN, Milton GW, et al. Eds. Cutaneous melanoma. 2nd ed. Philadelphia: JB Lippincott 1992;165-187.
15. Avril MF, Charpentier P, Margullis A, Guillaume JC. Regression of primary melanoma with metastasis. Cancer 1992;69:1377-1381.
16. Fallowfield ME, Cook MG. Vascular invsion in malignant melanomas. An independent prognostic variable ?. Am J Surg Pathol 1989;13:217-220.
17. Cohran AJ. Histology and prognosis in malignant melanomas. J Pathol 1969;97:459-468.
18. National Institutes of Health Consensus Development Panel on Early Melanoma. JAMMA 1992;268:1314:1319.
19. Harris MN,Shapiro RL, Roses DF. Malignant Melanoma. Primary Surgical Management (Excision and Node Dissection) Based on Pathology and Staging. Cancer 1995; 75:715-25.
20. Balch CM, Karakouses C, Mettlin C, Natarajan N, Donegan WL, Smart CR, et al. Management of melanoma in Unated States. Surg Gynecol Obstet 1984:158:311-318.
21. Sutherland CM, Chmiel JS, Henson DE. Cunningham MP, Peace BB, Winchester DP. Patient characteristic, methods of diagnosis and treatment of melanoma in the Unated States. Surg Gynecol Obstet 1984;175:129-134.
22. Ries LA, ankey BF, Miller BA, et al. Cancer statistics review 1973-1988. Whashintong, DC: National Cancer Institute: US Government Printing Office, 1991: NIH publications Nº, 91-2789.
23. Johnson TM, Smith JW, Nelson BR Chang A. Current therapy for cutaneous melanoma. J AM Acad Dermatol 1995;32:689-707.
24. Harrist TJ, Rigel DS, Day CL, et al. Microscopic satelites are more highly associated with lymph node metastasis than is primary melanoma thickness. Cancer 1984;53:2183-2187.
25. Balch CM, Soong SJ, Murad TM, Ingalls AL,
Maddox WA. A multifactorial analysis of melanoma. II. Prognostic
factors in patients with stage I (loclized) melanoma. Surgery
1979;86:343-51.
|
